Surgery plus ELFE (epirubicin, leucovorin, 5-fluorouracil and etoposide) vs surgery alone in radically resected gastric cancer (GC): Final results of a randomised phase III trial by the Gruppo Oncologico dell' Italia Meridionale (GOIM).

被引：0
|
作者：
De Vita, F.
Giuliani, F.
Gebbia, V.
Galizia, G.
Orditura, M.
Maiello, E.
Romito, S.
Carteni, G.
Manzione, L.
Catalano, G.
Colucci, G.
机构：
[1] Univ Naples, Naples, Italy
[2] Natl Canc Inst, Bari, Italy
[3] La Maddalena Canc Ctr, Palermo, Italy
[4] Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
[5] Civil Hosp, Campobasso, Italy
[6] Caldarelli Hosp, Naples, Italy
[7] San Carlo Hosp, Potenza, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4014
引用
收藏
页码：182S / 182S
页数：1
相关论文
共 22 条
  • [1] Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)
    De Vita, F.
    Giuliani, F.
    Orditura, M.
    Maiello, E.
    Galizia, G.
    Di Martino, N.
    Montemurro, F.
    Carteni, G.
    Manzione, L.
    Romito, S.
    Gebbia, V.
    Ciardiello, F.
    Catalano, G.
    Colucci, G.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 (08) : 1354 - 1358
  • [2] Chemotherapy versus control in radically resected gastric cancer:: A multicenter randomized phase III study by the Gruppo Oncologico Dell'Italia Meridionale (GOIM 2602)
    Giuliani, F.
    De Vita, F.
    Orditura, M.
    Maiello, E.
    Romito, S.
    Gebbia, V.
    Carteni, G.
    Manzione, L.
    Catalano, G.
    Colucci, G.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : VII149 - VII149
  • [3] Epirubicin, taxotere and fluorouracil modulated by folinic acid in the treatment of advanced gastric cancer: A phase II study of the Gruppo Oncologico dell' Italia Meridionale (GOIM)
    Giuliani, F.
    Romito, S.
    Maiello, E.
    Capobianco, A.
    Carrozza, F.
    Nugnes, I.
    Misino, A.
    Valerio, M. R.
    Manzione, L.
    Coiucci, G.
    [J]. EJC SUPPLEMENTS, 2008, 6 (14): : 107 - 112
  • [4] Folfiri vs xeliri in untreated advanced colorectal cancer: A phase II randomised trial of the gruppo oncologico dell'italia meridionale (Prot. Goim 2405)
    Colucci, G.
    Giuliani, F.
    De Vita, F.
    Di Bisceglie, M.
    Maiello, E.
    Romito, S.
    Caruso, M.
    Catalano, G.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : 22 - 23
  • [5] A randomized phase III trial of postoperative adjuvant chemotherapy versus surgery alone for radically resected gastric cancer (GC):: Final results of 9602 GOIM study
    De Vita, F.
    Giuliani, F.
    Orditura, M.
    Maiello, E.
    Manzione, L.
    Galizia, G.
    Romito, S.
    Gebbia, V
    Carteni, G.
    Catalano, G.
    Colucci, G.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : XI54 - XI54
  • [6] Vinorelbine and 5-fluorouracil bolus and/or continuous venous infusion plus levofolinic acid as second-line chemotherapy for metastatic breast cancer:: An analysis of results in clinical practice of the gruppo oncologico italia meridionale (GOIM)
    Gebbia, Vittorio
    Caruso, Michele
    Borsellino, Nicolo
    Ajello, Rosanna
    Tirrito, Maria Lina
    Chiarenza, Maurizio
    Valenza, Roberto
    Verderame, Francesco
    Varvara, Francesca
    Marrazzo, Antonio
    Bajardi, Eugenia
    Ferrau, Francesco
    Bordonaro, Roberto
    Tralongo, Paolo
    [J]. ANTICANCER RESEARCH, 2006, 26 (4B) : 3143 - 3150
  • [7] Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer
    M Moehler
    A Eimermacher
    J Siebler
    T Höhler
    A Wein
    M Menges
    D Flieger
    T Junginger
    T Geer
    E Gracien
    P R Galle
    M Heike
    [J]. British Journal of Cancer, 2005, 92 : 2122 - 2128
  • [8] Randomised phase II evaluation of irinotecan plus high-dose 5-fluorouracil and leucovorin (ILF) vs 5-fluorouracil, leucovorin, and etoposide (ELF) in untreated metastatic gastric cancer
    Moehler, M
    Eimermacher, A
    Siebler, J
    Höhler, T
    Wein, A
    Menges, M
    Flieger, D
    Junginger, T
    Geer, T
    Gracien, E
    Galle, PR
    Heike, M
    [J]. BRITISH JOURNAL OF CANCER, 2005, 92 (12) : 2122 - 2128
  • [9] EPIRUBICIN (E) IN COMBINATION WITH CISPLATIN (CDDP) AND CAPECITABINE (C) VERSUS DOCETAXEL (D) COMBINED WITH 5-FLUOROURACIL (5-FU) BY CONTINUOUS INFUSION (CI) AS FRONT-LINE THERAPY IN PATIENTS WITH ADVANCED GASTRIC CANCER (AGC): PRELIMINARY RESULTS OF A RANDOMISED PHASE II TRIAL OF THE GRUPPO ONCOLOGICO DELL'ITALIA MERIDIONALE
    Silvestris, N.
    De Vita, F.
    Romano, M. P.
    Maiello, E.
    Gebbia, V.
    Lorusso, V.
    Cinieri, S.
    Giuliani, F.
    Orditura, M.
    Colucci, G.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 227 - 227
  • [10] Epirubicin (E) in combination with cisplatin (CDDP) and capecitabine (C) versus docetaxel (D) combined with 5-fluorouracil (5-FU) by continuous infusion as front-line therapy in patients with advanced gastric cancer (AGC): Preliminary results of a randomized phase II trial of the Gruppo Oncologico Dell'Italia Meridionale
    Maiello, E.
    De Vita, F.
    Gebbia, V.
    Lorusso, V.
    Cinieri, S.
    Giuliani, F., Sr.
    Orditura, M.
    Fistola, E.
    Filippelli, G.
    Colucci, G., Sr.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
123